Trial intelligence / Profile preview

Phase 3 open-label study of sofosbuvir plus ribavirin in HCV/HIV co-infected subjects

2012-004154-28Phase 3Completed

Sponsor

Gilead Sciences

Start

Feb 2013

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1